. 2020 Apr 14;5(16):9301–9310. doi: 10.1021/acsomega.0c00189

Table 1. MICs of Cathelicidin-DM and Its Derivatives^a.

	MICs (μg/mL)
bacterial strains	cathelicidin-DM	cath-DM-CT1	cath-DM-CT2	cath-DM-CT3	cath-DM-NT	cath-DM-NCT1	cath-DM-NCT2	Amp	cathelicidin-DM after incubation in 50% serum
Gram-Positive Bacteria
S. haemolyticus (CI 1410970016)	12		6	3			3
E. faecalis (MDR 14U0445)	12							2
S. aureus ATCC25923	12	12						0.15
Gram-Negative Bacteria
E. coli ATCC25922	12							0.3
E. coli (MDR 13U1780)	12	12	12					32
E. coli (MDR 13A10022)	12							32
S. paratyphi A (CI 1410BL0513)	6	6		12			6	32	6
C. freundii (CI 1410UR0112)	12			6			12		12
K. pneumoniae (MDR 13U1752)	6			6				32	6
K. pneumoniae (MDR 13A11923)	6							32	6
K. pneumoniae (XDR 13A13361)	6	6		3			6	32	6

Note: CI, clinically isolated strain; MDR, multi-drug-resistant clinical isolate; XDR, extensive drug-resistant clinical isolate; (-) no detectable activity at a dose of 48 μg/mL.

Table 1. MICs of Cathelicidin-DM and Its Derivativesa.

Table 1. MICs of Cathelicidin-DM and Its Derivatives^a.